NCT00297739View on ClinicalTrials.gov

Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

April 30, 2005

Conditions
Aggression
Interventions
DRUG

Risperidone

Trial Locations (1)

33134

Jorge L. Armenteros, M.D., P.A., Coral Gables

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Armenteros, Jorge L., M.D., P.A.

INDIV

NCT00297739 - Risperidone Augmentation for Treatment-Resistant Aggression in ADHD | Biotech Hunter | Biotech Hunter